Gastric cancer: Update on diagnosis, staging, and therapy

Postgraduate Medicine

Volumn 102, Issue 4, 1997, Pages 231-241

  Latif, Alaa ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DIET; GASTRECTOMY; HELICOBACTER PYLORI; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR; STOMACH CANCER;

EID: 0030657881     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.10.343     Document Type: Review

References (25)

1. Whelan SL, Parkin DM, Masuyer E. Trends in cancer incidence and mortality. Lyon: International Agency for Research on Cancer, 1993 (IARC scientific publications No. 102)
2. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45(1):8-30 [Erratum, CA Cancer J Clin 1995;45(2):127-8]
3. Parkin D, Muir C, Whelan S, et al. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer, 1992
4. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 1993;218(5):583-92
5. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325(16):1127-31
6. Stemmermann GN. Intestinal metaplasia of the stomach: a status report. Cancer 1994;74(2):556-64
7. Brinton LA, Gridley G, Hrubec Z, et al. Cancer risk following pernicious anaemia. Br J Cancer 1989;59(5):810-3
8. Ramon JM, Serra L, Cerdo C, et al. Dietary factors and gastric cancer risk: a case-control study in Spain. Cancer 1993; 71(5):1731-5
9. Wu-Williams AH, Yu MC, Mack TM. Life-style, workplace, and stomach cancer by subsite in young men of Los Angeles County. Cancer Res 1990;50(9):2569-76
10. Bilzer T, Reifenberger G, Wechsler W. Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology. Neurotoxicol Teratol 1989;11(6):551-6
11. La Vecchia C, Ferraroni M, D'Avanzo B, et al. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomarkers Prev 1994;3(5):393-8
12. Demirer T, Icli F, Uzunalimoglu O, et al. Diet and stomach cancer incidence: a case-control study in Turkey. Cancer 1990; 65(10):2344-8
13. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104(5):1535-49
14. Levine MS, Creteur V, Kressel HY, et al. Benign gastric ulcers: diagnosis and follow-up with double-contrast radiography. Radiology 1987;164(1):9-13
15. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: Lippincott, 1992
16. Lightdale C, Botet J, Brennan M, et al. Endoscopic ultrasonography compared to computerized tomography for preoperative staging of gastric cancer. Gastrointest Endosc 1989;67:1181-8.
17. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994;8(3):533-53
18. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg 1989;209(2):162-6
19. Brady MS, Rogatko A, Dent LL, et al. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126(3):359-64
20. Noguchi Y, Imada T, Matsumoto A, et al. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989;64(10):2053-62
21. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220(2):176-82
22. Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11(8):1441-7
23. Wils JA, Klein HO, Wagener DJ, et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991;9:827-31.
24. Murad AM, Santiago FF, Petroianu A, et al. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993;72(1):37-41
25. Glimelius B, Hoffman K, Haglund U, et al. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. (Letter) Ann Oncol 1994;5(2): 189-90